Evidence map›Paper›PMID 35437846›Full record

ReviewJournal of orthopaedic research : official publication of the Orthopaedic Research Society2022

Current treatments for biofilm-associated periprosthetic joint infection and new potential strategies.

Anabelle Visperas, Daniel Santana, Alison K Klika, Carlos A Higuera-Rueda, Nicolas S Piuzzi

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. DTT-based biofilm and conventional intraoperative cultures for the detection of prosthetic joint infections: a comparative study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Methicillin-resistantiScience · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anabelle VisperasDepartment of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.ORCID 0000-0001-5431-3916
Daniel SantanaDepartment of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.ORCID 0000-0003-4697-1665
Alison K KlikaDepartment of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.ORCID 0000-0003-2755-0742
Carlos A Higuera-RuedaDepartment of Orthopaedic Surgery, Cleveland Clinic Florida, Weston, Florida, USA.ORCID 0000-0001-9143-2455
Nicolas S PiuzziDepartment of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.ORCID 0000-0003-3007-7538
Cleveland Clinic · USCleveland Clinic Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periprosthetic joint infection (PJI) remains a devastating complication after total joint arthroplasty. Bacteria involved in these infections are notorious for adhering to foreign implanted surfaces and generating a biofilm matrix. These biofilms protect the bacteria from antibiotic treatment and the immune system making eradication difficult. Current treatment strategies including debridement, antibiotics, and implant retention, and one- and two-stage revisions still present a relatively high overall failure rate. One of the main shortcomings that has been associated with this high failure rate is the lack of a robust approach to treating bacterial biofilm. Therefore, in this review, we will highlight new strategies that have the potential to combat PJI by targeting biofilm integrity, therefore giving antibiotics and the immune system access to the internal network of the biofilm structure. This combination antibiofilm/antibiotic therapy may be a new strategy for PJI treatment while promoting implant retention.

Indexed as

Arthritis, InfectiousProsthesis-Related InfectionsAnti-Bacterial AgentsBacteriaBiofilmsDebridementHumansAnti-Bacterial Agentsantibiofilm treatmentsbiofilminfectionperiprosthetic joint infection

Identifiers

PMID35437846
PMCPMC9322555
OpenAlexW4224219892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.